NCT00951132View on ClinicalTrials.gov

Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2009

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2013

Conditions
Depression
Interventions
DRUG

rosuvastatin

10mg tablets, once daily in three months

DRUG

Placebo

tablet, once daily, three months

Trial Locations (1)

1478

Akershus University Hospital, Lorenskog

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

collaborator

AstraZeneca

INDUSTRY

lead

University Hospital, Akershus

OTHER